The investigators conducted a multicenter, double-blind, placebo-controlled, active-controlled phase 3a trial (ClinicalTrials.gov ID: NCT05567796) evaluating the efficacy and safety of the combination of semaglutide and cagrilintide in adults without diabetes with a body-mass index (BMI) of greater than or equal to 30 or greater than or equal to 27 with at least one obesity-related complication
Men should work with qualified healthcare providers to ensure appropriate dosing and regular monitoring throughout treatment
Other receptors There are also other receptors on the platelet surface, including collagen receptors GPIa-IIa (thrombospondin, TSP), 120 C1q receptor, as well as coagulation and fibrinolytic protein receptors, 5-HT receptor, and the membrane protein GPIV/CD36
Report any mood changes to your GP or prescribing clinician promptly
During your period, blood sugar naturally fluctuates, and some individuals experience lower blood pressure, which can compound dizziness or fatigue from the medication
Though rare, the drugs potential side effects include severe conditions like pancreatitis, vision loss, blood clots, gastrointestinal conditions, and kidney damage
![role of rebates in glp-1 pbm decisions Employers' New Decision Point: Whether to Cover Expensive Weight Loss Drugs [Weekly Roundup] TransparentRx Prescription savings under PBMs and –](https://transparentrx.com/wp-content/uploads/2023/06/rebates.png)
